Free Trial
NASDAQ:CEPT

Cantor Equity Partners II 11/14/2025 Earnings Report

Cantor Equity Partners II logo
$12.13 +0.03 (+0.27%)
As of 02:46 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Cantor Equity Partners II EPS Results

Actual EPS
$0.08
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cantor Equity Partners II Revenue Results

Actual Revenue
$2.56 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cantor Equity Partners II Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Cantor Equity Partners II Earnings Headlines

Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide. On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.tc pixel
See More Cantor Equity Partners II Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cantor Equity Partners II? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cantor Equity Partners II and other key companies, straight to your email.

About Cantor Equity Partners II

Cantor Equity Partners II (NASDAQ:CEPT) (NASDAQ: CEPT) is a closed-end management investment company that focuses on providing customized capital solutions to private, middle-market companies in the United States. Listed on the Nasdaq, CEPT seeks to deliver attractive risk-adjusted returns by investing across a spectrum of debt and equity instruments. Its portfolio may include senior secured loans, subordinated and mezzanine debt, preferred equity, and common equity, allowing it to tailor financing structures to meet the specific growth, acquisition or recapitalization needs of its portfolio companies.

As a business development company registered under the Investment Company Act of 1940, CEPT targets U.S. companies with demonstrated cash flow and growth potential. While it invests across various industry sectors—including healthcare, business services, technology and industrials—the fund typically looks for established enterprises seeking between $10 million and $75 million of capital. Through this diversification, CEPT aims to balance current income generation with the prospect of long-term capital appreciation.

The company is externally managed by Cantor Fitzgerald Equity Partners LLC, the private equity affiliate of global financial services firm Cantor Fitzgerald & Co. Cantor Fitzgerald Equity Partners draws on more than three decades of experience in middle-market investing, leveraging an established deal-sourcing platform and deep industry relationships. CEPT’s management team comprises seasoned investment professionals who oversee sourcing, underwriting and portfolio monitoring on behalf of shareholders.

View Cantor Equity Partners II Profile